Neurobiological Technologies, Inc. to present at the Rodman & Renshaw 8th Annual Healthcare Conference
November 01 2006 - 8:45AM
PR Newswire (US)
EMERYVILLE, Calif., Nov. 1 /PRNewswire-FirstCall/ --
Neurobiological Technologies, Inc. (NASDAQ:NTII), (NTI(R)), a
biotechnology company engaged in the business of acquiring and
developing central nervous system related drug candidates, today
announced that Paul E. Freiman, President and Chief Executive
Officer will make a company presentation at the Rodman &
Renshaw 8th Annual Healthcare Conference in New York. The
conference is being held November 6-8, 2006, at the New York Palace
Hotel. Mr. Freiman will present the NTI story on November 7, at
3:30 pm in the Villard Ballroom. The presentation will be web cast
and available on the NTI website ( http://www.ntii.com/ ) at the
following link: http://www.shareholder.com/ntii/medialist.cfm About
Neurobiological Technologies, Inc. NTI is a drug development
company focused on the clinical evaluation and regulatory approval
of neuroscience drugs. The Company's strategy is to in-license and
develop early- and later-stage drug candidates that target major
medical needs and which can be rapidly commercialized. NTI's
experienced management team oversees the human clinical trials
necessary to establish preliminary evidence of efficacy. We
anticipate that we will continue to acquire and develop late-stage
neurologic drug candidates and will develop the resources to market
these drugs in selected world regions. Our goal is to develop and
market drug candidates in the United States, Europe and Asia and we
may seek partnerships with pharmaceutical and biotechnology
companies to assist us. DATASOURCE: Neurobiological Technologies,
Inc. CONTACT: Paul E. Freiman, President and CEO of Neurobiological
Technologies, Inc., +1-510-595-6000; or Marlon Nurse, VP, Investor
Relations, of Porter, LeVay & Rose, Inc., +1-212-564-4700, for
Neurobiological Technologies, Inc. Web site: http://www.ntii.com/
Copyright
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Jul 2024 to Aug 2024
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Aug 2023 to Aug 2024